Advisors Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,573
| Closed | -$9.11K | – | 1473 |
|
|
2025
Q1 | $9.11K | Sell |
2,573
-1,329
| -34% | -$4.7K | ﹤0.01% | 1412 |
|
|
2024
Q4 | $14.8K | Sell |
3,902
-3,751
| -49% | -$14.2K | ﹤0.01% | 1392 |
|
|
2024
Q3 | $24.8K | Sell |
7,653
-686
| -8% | -$2.22K | ﹤0.01% | 1368 |
|
|
2024
Q2 | $15.8K | Sell |
8,339
-11
| -0.1% | -$21 | ﹤0.01% | 1389 |
|
|
2024
Q1 | $23.7K | Sell |
8,350
-273
| -3% | -$775 | ﹤0.01% | 1355 |
|
|
2023
Q4 | $127K | Sell |
8,623
-20
| -0.2% | -$294 | ﹤0.01% | 1172 |
|
|
2023
Q3 | $158K | Buy |
8,643
+2,780
| +47% | +$50.9K | ﹤0.01% | 1141 |
|
|
2023
Q2 | $126K | Buy |
5,863
+1,218
| +26% | +$26.3K | ﹤0.01% | 1181 |
|
|
2023
Q1 | $136K | Buy |
4,645
+740
| +19% | +$21.7K | ﹤0.01% | 1181 |
|
|
2022
Q4 | $144K | Buy |
+3,905
| New | +$144K | ﹤0.01% | 1177 |
|